Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-02-01

Clinical Trial Update: Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing HAART to statin therapy in HIV infection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HAART (Highly Active Antiretroviral Therapy)
  • Statin therapy (statin)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection | Phase 2 | Status: WITHDRAWN